Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zebrafish | 20 | 2024 | 422 | 6.460 |
Why?
|
| Zebrafish Proteins | 12 | 2024 | 130 | 4.510 |
Why?
|
| Embryo, Nonmammalian | 11 | 2024 | 139 | 2.400 |
Why?
|
| Receptors, G-Protein-Coupled | 5 | 2024 | 298 | 2.240 |
Why?
|
| Endocrine Disruptors | 5 | 2022 | 57 | 1.880 |
Why?
|
| Receptors, Aryl Hydrocarbon | 3 | 2026 | 70 | 1.660 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 2 | 2023 | 2 | 1.560 |
Why?
|
| Receptors, Estrogen | 8 | 2019 | 727 | 1.560 |
Why?
|
| Estradiol | 8 | 2020 | 483 | 1.510 |
Why?
|
| Estrogens | 8 | 2022 | 436 | 1.280 |
Why?
|
| Response Elements | 2 | 2026 | 99 | 1.050 |
Why?
|
| Green Fluorescent Proteins | 5 | 2016 | 382 | 1.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2026 | 148 | 0.920 |
Why?
|
| Edema, Cardiac | 1 | 2024 | 3 | 0.900 |
Why?
|
| Receptors, Androgen | 3 | 2024 | 411 | 0.850 |
Why?
|
| Models, Animal | 3 | 2024 | 459 | 0.810 |
Why?
|
| Adaptive Immunity | 1 | 2024 | 100 | 0.800 |
Why?
|
| Liver | 4 | 2026 | 1790 | 0.790 |
Why?
|
| Larva | 4 | 2017 | 252 | 0.790 |
Why?
|
| Animals, Genetically Modified | 8 | 2022 | 331 | 0.740 |
Why?
|
| Adjuvants, Immunologic | 1 | 2024 | 392 | 0.740 |
Why?
|
| Immunity, Innate | 1 | 2024 | 409 | 0.700 |
Why?
|
| Genes, Reporter | 3 | 2022 | 350 | 0.690 |
Why?
|
| Animals | 24 | 2026 | 34278 | 0.690 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 90 | 0.680 |
Why?
|
| Water Pollutants, Chemical | 2 | 2019 | 37 | 0.670 |
Why?
|
| Receptors, Steroid | 1 | 2021 | 172 | 0.660 |
Why?
|
| DNA | 1 | 2026 | 1444 | 0.650 |
Why?
|
| Animal Fins | 1 | 2019 | 2 | 0.620 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 2019 | 6 | 0.620 |
Why?
|
| Endothelial Cells | 1 | 2023 | 536 | 0.610 |
Why?
|
| Cardiotoxicity | 1 | 2019 | 43 | 0.600 |
Why?
|
| Vaccines | 1 | 2024 | 385 | 0.600 |
Why?
|
| Testosterone | 1 | 2024 | 603 | 0.590 |
Why?
|
| Sex Determination Analysis | 1 | 2018 | 15 | 0.580 |
Why?
|
| Sex Differentiation | 1 | 2018 | 19 | 0.560 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2024 | 1000 | 0.560 |
Why?
|
| Skull | 1 | 2019 | 152 | 0.540 |
Why?
|
| Oogenesis | 1 | 2018 | 52 | 0.540 |
Why?
|
| Genomics | 1 | 2026 | 1617 | 0.540 |
Why?
|
| Craniofacial Abnormalities | 1 | 2019 | 255 | 0.530 |
Why?
|
| Receptor Cross-Talk | 1 | 2017 | 36 | 0.530 |
Why?
|
| Microscopy, Fluorescence | 3 | 2016 | 312 | 0.520 |
Why?
|
| Spermatogenesis | 1 | 2018 | 172 | 0.510 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2017 | 191 | 0.490 |
Why?
|
| Ovary | 1 | 2018 | 365 | 0.480 |
Why?
|
| Testis | 1 | 2018 | 413 | 0.470 |
Why?
|
| Heart Rate | 1 | 2017 | 578 | 0.430 |
Why?
|
| Molecular Imaging | 1 | 2011 | 61 | 0.330 |
Why?
|
| Gene Expression Regulation | 3 | 2026 | 2344 | 0.310 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 415 | 0.310 |
Why?
|
| Estrogen Antagonists | 3 | 2016 | 93 | 0.300 |
Why?
|
| Signal Transduction | 7 | 2024 | 4645 | 0.300 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 1625 | 0.280 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 239 | 0.270 |
Why?
|
| Nucleotide Motifs | 1 | 2026 | 50 | 0.240 |
Why?
|
| Cell Nucleus | 2 | 2018 | 564 | 0.220 |
Why?
|
| Ligands | 2 | 2016 | 485 | 0.200 |
Why?
|
| Mutation | 3 | 2024 | 6144 | 0.190 |
Why?
|
| Androgens | 1 | 2024 | 275 | 0.190 |
Why?
|
| Dimerization | 1 | 2022 | 139 | 0.190 |
Why?
|
| Mammals | 1 | 2022 | 259 | 0.170 |
Why?
|
| Aging | 1 | 2008 | 1257 | 0.170 |
Why?
|
| Biliary Tract | 1 | 2020 | 11 | 0.170 |
Why?
|
| Ethinyl Estradiol | 2 | 2017 | 11 | 0.160 |
Why?
|
| Estrogen Receptor beta | 1 | 2020 | 81 | 0.160 |
Why?
|
| Heart | 1 | 2024 | 674 | 0.160 |
Why?
|
| Folate Receptor 1 | 1 | 2019 | 30 | 0.160 |
Why?
|
| Phenols | 2 | 2017 | 72 | 0.160 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2019 | 43 | 0.150 |
Why?
|
| Benzhydryl Compounds | 2 | 2017 | 76 | 0.150 |
Why?
|
| Embryonic Development | 2 | 2019 | 223 | 0.150 |
Why?
|
| Cell Membrane | 1 | 2021 | 463 | 0.150 |
Why?
|
| Sex Ratio | 1 | 2018 | 12 | 0.150 |
Why?
|
| Male | 8 | 2026 | 64823 | 0.140 |
Why?
|
| Time Factors | 3 | 2017 | 6275 | 0.140 |
Why?
|
| Halogenated Diphenyl Ethers | 1 | 2017 | 12 | 0.140 |
Why?
|
| Triiodothyronine | 1 | 2017 | 56 | 0.130 |
Why?
|
| Pituitary Gland | 1 | 2017 | 78 | 0.130 |
Why?
|
| Folic Acid | 1 | 2019 | 285 | 0.130 |
Why?
|
| Female | 9 | 2020 | 70755 | 0.130 |
Why?
|
| Cyclosporine | 1 | 2017 | 130 | 0.130 |
Why?
|
| Oocytes | 1 | 2018 | 288 | 0.120 |
Why?
|
| Brain | 1 | 2008 | 3161 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 1 | 2026 | 4738 | 0.120 |
Why?
|
| Fertility | 1 | 2018 | 264 | 0.120 |
Why?
|
| Workflow | 1 | 2016 | 138 | 0.110 |
Why?
|
| Hemangioblasts | 1 | 2014 | 2 | 0.110 |
Why?
|
| Automation | 1 | 2014 | 67 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2023 | 2430 | 0.100 |
Why?
|
| Genotype | 1 | 2018 | 2651 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 339 | 0.090 |
Why?
|
| Phytoestrogens | 1 | 2011 | 13 | 0.090 |
Why?
|
| Consensus Sequence | 1 | 2011 | 53 | 0.090 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2011 | 14 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 54 | 0.090 |
Why?
|
| Age Factors | 1 | 2017 | 2866 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2011 | 400 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 551 | 0.080 |
Why?
|
| Uterus | 1 | 2014 | 550 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 996 | 0.080 |
Why?
|
| Endocrine System | 1 | 2008 | 18 | 0.070 |
Why?
|
| Humans | 6 | 2024 | 130931 | 0.070 |
Why?
|
| Mice | 1 | 2026 | 18410 | 0.070 |
Why?
|
| Hepatocytes | 2 | 2020 | 235 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1383 | 0.070 |
Why?
|
| Morpholinos | 2 | 2020 | 9 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 1217 | 0.070 |
Why?
|
| Germ Cells | 1 | 2008 | 201 | 0.070 |
Why?
|
| Transcriptome | 1 | 2013 | 1144 | 0.060 |
Why?
|
| Cell Line | 2 | 2020 | 2596 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 1123 | 0.060 |
Why?
|
| Neurons | 1 | 2011 | 1978 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2019 | 36 | 0.040 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2019 | 14 | 0.040 |
Why?
|
| Oxazines | 1 | 2019 | 30 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 379 | 0.040 |
Why?
|
| Liver Regeneration | 1 | 2019 | 39 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2019 | 25 | 0.040 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2019 | 52 | 0.040 |
Why?
|
| Pyridones | 1 | 2019 | 144 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2019 | 238 | 0.030 |
Why?
|
| Piperazines | 1 | 2019 | 268 | 0.030 |
Why?
|
| Organ Size | 1 | 2019 | 435 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2019 | 428 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2019 | 448 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2019 | 352 | 0.030 |
Why?
|
| Stem Cells | 1 | 2020 | 711 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1344 | 0.030 |
Why?
|
| Receptors, Estradiol | 1 | 2014 | 2 | 0.030 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2014 | 9 | 0.030 |
Why?
|
| Ephrin-B2 | 1 | 2014 | 9 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1500 | 0.030 |
Why?
|
| Heat-Shock Response | 1 | 2014 | 34 | 0.030 |
Why?
|
| Genistein | 1 | 2014 | 39 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 66 | 0.030 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2014 | 40 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2013 | 53 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 153 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1941 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 451 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 419 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2014 | 204 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 899 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 2459 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 1235 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 598 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 1009 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 433 | 0.020 |
Why?
|
| HIV Infections | 1 | 2019 | 2031 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 7558 | 0.020 |
Why?
|